Human
Genome Sciences (NASDAQ:HGSI) plunged 8.91% to $24.12. The
52-week range of the stock is $20.56-$34.49. The stock went down more than 21%
year-to-date.
The
stock has average daily volume of 3.11 million shares. At current market price,
the market capitalization of the company stands at $4.56 billion.
Gilead
Sciences, Inc. (NASDAQ:GILD) lost 2.46% to $38.02. The
52-week range of the stock is $31.73-$49.50. The stock went down more than 12%
year-to-date.
The stock
opened at $38.50 and is trading within the range of $38-$38.70. At current
market price, the market capitalization of the company stands at $31 billion.
OXiGENE,
Inc. (NASDAQ:OXGN) went down 1.96% to $0.265. The 52-week range
of the stock is $0.21-$1.70. The stock went down more than 76% year-to-date.
The
stock has average daily volume of 1.88 million shares. At current market price,
the market capitalization of the company stands at $19.46 million.
Amgen,
Inc. (NASDAQ:AMGN) is trading 0.28% lower to $54.47. The 52-week
range of the stock is $50.26-$61.26. The stock went down more than 3%
year-to-date.
The
average daily volume of the stock is 6.03 million shares. At current market
price, the market capitalization of the company stands at $51.86 billion.
For our full disclosure please visit - http://www.wallstreetgrand.com/disclosure.html
